Diane Logan

915 total citations
17 papers, 373 citations indexed

About

Diane Logan is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, Diane Logan has authored 17 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Diane Logan's work include Neuroendocrine Tumor Research Advances (3 papers), BRCA gene mutations in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Diane Logan is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), BRCA gene mutations in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Diane Logan collaborates with scholars based in Canada and United States. Diane Logan's co-authors include William K. Evans, Alasdair G. W. Hunter, Lauren Humphreys, Linda Surh, Judith Allanson, Mario Cappelli, S. Verma, Quincy S. Chu, Jean A. Mackay and Mark Vincent and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Quality of Life Research.

In The Last Decade

Diane Logan

17 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Logan Canada 10 179 142 89 67 53 17 373
Kristen J. Vogel United States 13 125 0.7× 231 1.6× 100 1.1× 26 0.4× 37 0.7× 19 430
S. Verma Canada 13 217 1.2× 160 1.1× 70 0.8× 62 0.9× 50 0.9× 20 450
Ingrid Slade United Kingdom 9 106 0.6× 238 1.7× 132 1.5× 22 0.3× 51 1.0× 10 431
Maria Litwiniuk Poland 10 245 1.4× 88 0.6× 117 1.3× 74 1.1× 18 0.3× 52 442
Anne‐Bine Skytte Denmark 14 94 0.5× 243 1.7× 154 1.7× 89 1.3× 59 1.1× 40 506
Monica Emanuelsson Sweden 13 149 0.8× 225 1.6× 120 1.3× 159 2.4× 20 0.4× 19 525
R Davidson United Kingdom 9 120 0.7× 346 2.4× 159 1.8× 28 0.4× 92 1.7× 12 511
Julie Erlichman United States 8 102 0.6× 279 2.0× 96 1.1× 36 0.5× 35 0.7× 9 382
Sudeshna Chatterjee‐Paer United States 6 124 0.7× 77 0.5× 45 0.5× 30 0.4× 21 0.4× 8 271
Marianne Hinkula Finland 11 136 0.8× 39 0.3× 56 0.6× 39 0.6× 63 1.2× 14 386

Countries citing papers authored by Diane Logan

Since Specialization
Citations

This map shows the geographic impact of Diane Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Logan more than expected).

Fields of papers citing papers by Diane Logan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Logan. The network helps show where Diane Logan may publish in the future.

Co-authorship network of co-authors of Diane Logan

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Logan. A scholar is included among the top collaborators of Diane Logan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Logan. Diane Logan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Baines, Kelly J., Wilson H. Miller, Rahima Jamal, et al.. (2025). Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial. Journal for ImmunoTherapy of Cancer. 13(8). e012659–e012659. 2 indexed citations
2.
Miller, Wilson H., Bertrand Routy, Rahima Jamal, et al.. (2022). Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.. Journal of Clinical Oncology. 40(16_suppl). 9533–9533. 8 indexed citations
3.
Roth, Kathryn, et al.. (2021). Real-World Experience of Vismodegib in Advanced Basal Cell Carcinoma at a Canadian Cancer Center. Journal of Cutaneous Medicine and Surgery. 26(2). 143–148. 1 indexed citations
4.
Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2020). Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast Cancer Research and Treatment. 183(2). 365–372. 11 indexed citations
5.
Breadner, Daniel, Mark Vincent, Rohann Correa, et al.. (2020). Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study.. Journal of Clinical Oncology. 38(15_suppl). 3530–3530. 2 indexed citations
6.
Borrie, Adrienne E., Yun‐Hee Choi, Francisco Perera, et al.. (2018). Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast Cancer Research and Treatment. 172(2). 371–379. 11 indexed citations
7.
Baetz, Tara, Xinni Song, D. Scott Ernst, et al.. (2018). A randomized phase III study of duration of anti-PD-1 therapy in metastatic melanoma (STOP-GAP): Canadian Clinical Trials Group study (CCTG) ME.13.. Journal of Clinical Oncology. 36(15_suppl). TPS9600–TPS9600. 9 indexed citations
8.
Chu, Quincy S., Mark Vincent, Diane Logan, Jean A. Mackay, & William K. Evans. (2005). Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline. Lung Cancer. 50(3). 355–374. 81 indexed citations
9.
Cappelli, Mario, Linda Surh, Lauren Humphreys, et al.. (2001). Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing. Quality of Life Research. 10(7). 595–607. 33 indexed citations
10.
Cappelli, Mario, Linda Surh, Mark Walker, et al.. (2001). Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychology Health & Medicine. 6(3). 321–333. 24 indexed citations
11.
Cappelli, Mario, Linda Surh, Lauren Humphreys, et al.. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics. 55(6). 419–430. 97 indexed citations
12.
Evans, William K., Craig C. Earle, David J. Stewart, et al.. (1997). Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer. Lung Cancer. 18(1). 83–94. 12 indexed citations
13.
Stewart, David J., Eva Tomiak, Glenwood Goss, et al.. (1996). Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer. Lung Cancer. 15(1). 115–123. 15 indexed citations
14.
Stewart, David J., William K. Evans, & Diane Logan. (1994). Addition of Pentoxifylline plus Nifedipine to Chemotherapy in Patients with Cisplatin-Resistant Cancers of the Lung and Other Sites. American Journal of Clinical Oncology. 17(4). 313–316. 6 indexed citations
15.
Evans, William K., Frances A. Shepherd, Diane Logan, et al.. (1994). VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer. European Journal of Cancer. 30(3). 299–303. 10 indexed citations
16.
Horbelt, Douglas V., Jake Delmore, Roland Meisel, et al.. (1994). Mixed germ cell malignancy of the ovary concurrent with pregnancy.. PubMed. 84(4 Pt 2). 662–4. 46 indexed citations
17.
Evans, William K., Diane Logan, J. Maroun, et al.. (1993). A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer. Lung Cancer. 10(3-4). 281–281. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen J. Vogel Breakdown of academic impact, for papers by S. Verma Breakdown of academic impact, for papers by Ingrid Slade Breakdown of academic impact, for papers by Maria Litwiniuk Breakdown of academic impact, for papers by Anne‐Bine Skytte Breakdown of academic impact, for papers by Monica Emanuelsson Breakdown of academic impact, for papers by R Davidson Breakdown of academic impact, for papers by Julie Erlichman Breakdown of academic impact, for papers by Sudeshna Chatterjee‐Paer Breakdown of academic impact, for papers by Marianne Hinkula
Rankless by CCL
2026